Institute of Chinese Pharmaceutical Sciences, College of Pharmacy, China Medical University, 91 Hsueh-Shih Road, Taichung, Taiwan.
Am J Chin Med. 2011;39(2):349-65. doi: 10.1142/S0192415X11008877.
This study investigated the protective effect of the aqueous extract of Flemingia macrophylla (AFM) against hepatic injury induced by CCl(4). Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) were detected as biomarkers in the blood to indicate hepatic injury. Product of lipid peroxidation (MDA), superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GSH-Px), and reduced glutathione (GSH) contents were evaluated for oxidative stress in hepatic injury. Moreover, histopathological observation was assayed for the degree of hepatic injury. After oral administration of AFM, 0.5 g/kg and 1.0 g/kg doses significantly decreased ALT and AST, attenuated the histopathology of hepatic injury, ameliorated oxidative stress in hepatic tissue, and increased the activities of CAT, SOD and GSH-Px. The hepatoprotective effect of daidzein and genistein were consistent to that of AFM. This study demonstrated for the first time that AFM has hepatoprotective effect on acute liver injuries induced by CCl(4), and the results suggested that the effect of AFM against CCl(4)-induced liver damage was related to antioxidant properties.
本研究旨在探讨水飞蓟素(AFM)对 CCl(4)诱导的肝损伤的保护作用。丙氨酸氨基转移酶(ALT)和天冬氨酸氨基转移酶(AST)作为血液中的生物标志物,用于指示肝损伤。脂质过氧化产物(MDA)、超氧化物歧化酶(SOD)、过氧化氢酶(CAT)、谷胱甘肽过氧化物酶(GSH-Px)和还原型谷胱甘肽(GSH)含量用于评估肝损伤中的氧化应激。此外,还进行了肝损伤程度的组织病理学观察。AFM 口服给药 0.5 g/kg 和 1.0 g/kg 剂量后,可显著降低 ALT 和 AST,减轻肝组织的组织病理学损伤,改善肝组织氧化应激,并增加 CAT、SOD 和 GSH-Px 的活性。大豆苷元和染料木黄酮的保肝作用与 AFM 一致。本研究首次证明 AFM 对 CCl(4)诱导的急性肝损伤具有保护作用,结果表明 AFM 对 CCl(4)诱导的肝损伤的作用与抗氧化特性有关。